Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Antti Vuolanto appointed as CEO of Herantis as of 22 July 2022

Herantis Pharma PlcCompany release, Inside information, 8 July 2022 at 1 p.m. EEST The Board of Directors of Herantis Pharma Plc has appointed Antti Vuolanto (born 1975) as CEO as of 22July2022. Frans Wuite will continue as interim CEO of Herantis Pharma Plc until 21July2022 and as Member of the Board also thereafter. Antti Vuolanto has acted as the Chief Operating Officer of Herantis Pharma Plc since 2018. Vuolanto graduated as Doctor of Science in Technology at Aalto University, Finland in 2004 in biochemistry and bioprocess technology. He has vast experience in biological drug

Blog: Indoor air right now – international experts meet in Indoor Air 2022 -conference

The international Indoor Air Conference ,) was organised between 12 and 16 June 2022, with visitors from 42 countries. There was a sense of joy in the air as scientific experts were once again, with travel restrictions being lifted, able to share information with each other face to face, not just virtually. Use of sensors a hot topic Global trends at the moment include indoor air sensors and various ventilation themes. As buildings become more automated, there is increasing interest in the continuous monitoring of carbon dioxide and volatile organic

SBB sells 23 properties in Finspång Municipality at an agreed property value of SEK 1.35 billion

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) is selling 23 properties in Finspång Municipality to Gladsheim Fastigheter AB. The properties have a total lettable area of approximately 86,000 sqm, of which 74 percent consists of living space and the remaining part of commercial space. The properties generate annual rental income of approximately SEK 96 million, of which approximately 74 percent comes from residential tenants. The total agreed property value of SEK 1.35 billion before deduction of deferred tax is in line with the book value. "According to plan, we continue to sell

SkartaNYAB and Uusiutuva Energia Karahka Oy have signed a BoP agreement for a Karahka wind park in Oulainen

SkartaNYAB PlcCOMPANY ANNOUNCEMENT08 July 2022 at 12.40SkartaNYAB and Uusiutuva Energia Karahka Oy have signed a BoP agreement for a Karahka wind park in Oulainen Skarta Finland Oy, a company that belongs to SkartaNYAB Group, has entered into a Balance of Plant (BoP) agreement with Uusiutuva Energia Karahka Oy, on building a wind park in Oulaisten city in Northern Ostrobothnia. The value of the contract is approximately EUR 32 million. The construction work starts in autumn and the works will be finished for the wind turbine generator installation work in spring 2024. The completion

Fabege continues share buy-back

Fabege AB (publ) has started the share buy-back programme approved by the Annual General Meeting on 29 March 2022. The AGM authorised the Board for a period no later than the next AGM to acquire Fabege shares. The shares acquired may not exceed 10 per cent of the total number of outstanding Fabege shares at any time.The purpose of the buy-back programme is to enable the Company to continuously adapt its capital requirements and thereby improve shareholder value. The repurchases will be made on the Stockholm Stock Exchange at a price within the registered share price interval on each

Reminder: Invitation to DNB's second quarter presentation, Tuesday, 12 July 2022

DNB will publish its results for the second quarter of 2022 on Tuesday, 12 July 2022 at 7.30 CET. 9:30 CET: Presentation CEO Kjerstin Braathen and CFO Ida Lerner present the results at a live streamed press conference. It will be possible to ask questions online and a broadcast will be available on the Investor Relations pages at ir.dnb.no. It will also be possible to physically attend the presentation at DNB's head office in Bjørvika, Dronning Eufemias gate 30. Please register your attendance in Oslo, at ca@dnb.no. 13:30 CET: Conference call for analysts and investors Call in

Change in the holding of Kesko Corporation's treasury shares

Today a total of 1,003 B shares (KESKOB) have been returned to Kesko Corporation without consideration in accordance with the terms and conditions of Kesko's share-based commitment and incentive plan PSP 2019-2022. The shares had initially been granted to a person included in the target group of the 2019-2020 performance period of the plan. Following the return of the shares, Kesko holds 2,621,861 of its own B shares as treasury shares. Further information is available from Matti Mettälä, Executive Vice President, tel. +358 105 322 200. Kesko Corporation DISTRIBUTIONNasdaq

BioStock: Positive phase I results for Saniona

The results are in from biopharma Saniona’s phase I clinical trial with SAN711 and they are positive. Data from the trial demonstrated that SAN711 was safe and well-tolerated across all dosing cohorts with a favourable absorption and distribution profile. With these results, the path lies open for continued clinical development of SAN711. BioStock reached out to Saniona’s CEO to comment the results.Read the full article at biostock.se:https://www.biostock.se/en/2022/07/positive-phase-i-results-for-saniona/This is a press release from BioStock - Connecting Innovation & Capital. https://

Minesto's tidal power plant in grid-connected operation - commercial performance verified

Leading marine energy developer Minesto has according to plan successfully commissioned the first unit of tidal power plant “Dragon 4” in grid-connected operation in Vestmannasund, Faroe Islands. The company announces today that the commissioning results verify commercial performance and are fully in line with simulation results.The first tidal power plant from Minesto's product line Dragon Class, Dragon 4 (100 kW), has been commissioned in Vestmannasund, Faroe Islands, in early summer. The first phase of electricity generation shows that predicted performance is achieved in line with

BioStock: Chordate sums up H1 and projects sales growth

It has been an eventful first half of the year for Chordate Medical, including a list change to Nasdaq First North and an ongoing market introduction in Saudi Arabia and the UK. In addition, the company has fully recruited the migraine study and completed the first phase of the process to obtain market approval in the United States. BioStock had a chat with CEO Anders Weilandt about these events and his expectations for the autumn.Read the full article at biostock.se: https://www.biostock.se/en/2022/07/chordate-sums-up-h1-and-projects-sales-growth/ This is a press release from

Scandinavian Biogas´report for the second quarter and invitation to a digital conference on the 20[th] of July, 2022

Scandinavian Biogas will publish the report for the second quarter of 2022 on Wednesday the 20[th] of July at approximately 07.30. A conference meeting for investors, analysts and the media will be held at 10.00 the same day. The report will be presented at the conference call by CEO Matti Vikkula and CFO Anna Budzynski. The presentation will be held in English and will begin with a short presentation of the report followed by a question-and-answer session. To participate in the conference call, use this Teamslink 

NCC divests trenchless pipe installation operations to No Dig Alliance

NCC is selling NoDig, the company’s Swedish and Norwegian trenchless pipe installation operations, to No Dig Alliance. The transaction is expected to be completed in the third quarter of 2022.NCC’s decision to sell NCC NoDig, a trenchless pipe installation solution, is based on it having few synergies with other parts of NCC and the fact that its differs from NCC Infrastructure’s other project activities. The buyer is No Dig Alliance, which conducts trenchless pipe installation operations in Sweden, Norway and Finland. “With its strong customer base and sector-leading expertise, NCC

SynAct Pharma AB publishes prospectus for list change to Nasdaq Stockholm

SynAct Pharma AB (“SynAct” or the “Company”) announced on June 28, 2022 that Nasdaq Stockholm’s listing committee has approved that the company’s shares are admitted to trading on Nasdaq Stockholm Main Market. The prospectus that has been prepared in connection with the list change has today been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and is now available on SynAct’s website, www.synactpharma.com, and will be available on the Swedish Financial Supervisory Authority’s website, www.fi.se.A listing of the Company’s shares on Nasdaq

BioStock: Köping Hockey Chairman puts player safety first

Köping Hockey is a third tier ice hockey team in Sweden, and its players do not get the same benefits as those in top league, the SHL. However, Köping chairman Anders Näsström strongly believes in player safety, and has thus invested in PolarCool’s brain cooling device PolarCap for concussion treatment. BioStock reached out to Näsström to get his take.Read the interview with Anders Näsström at biostock.se: https://www.biostock.se/en/2022/07/koping-hockeys-ordforande-satter-spelarnas-sakerhet-forst/This is a press release from BioStock - Connecting Innovation & Capital. https://www.

BioStock: Evaxion Biotech expands its programme with a new indication

Danish Evaxion Biotech, which develops AI-based immunotherapies, has seen encouraging preclinical results with the candidate EVX-03. The company is therefore expanding its programme to include the indication of non-small cell lung cancer. Evaxion plans to submit a regulatory filing in the second half of 2022 for a clinical study within the new indication, which the company believes significantly increases the technology’s possibilities.Read the article at biostock.se: https://www.biostock.se/en/2022/07/evaxion-biotech-utokar-sitt-program-med-ny-indikation/This is a press release from

Nordic Mining is progressing construction works at Engebø

Nordic Mining ASA (“Nordic Mining” or the “Company”) reports on good progress on construction works at Engebø initiated in April 2022, following acquisition of the main properties, giving immediate access to the process plant area.   The construction works is undertaken by EPC1, Sunnfjord Industripartner AS (“SIPA”), under the lump-sum EPC (“Engineering, Procurement and Construction”) contract signed in November 2021. In total 1,300 meters of construction road has been constructed. This will allow transportation of soil and stone up to a mass deposit, which has been set up at

Welcome Stena Ebba, the newest addition to Stena Line´s Baltic Sea E-Flexers

Stena Line introduces the second large E-Flexer of its Baltic Sea expansion, to operate Karlskrona-Gdynia with its sister vessel Stena EstelleStena Line introduces the second of the two large E-Flexer class vessels to be deployed on the route Karlskrona-Gdynia: In December 2022, the brand new Stena Ebba will join her sister Stena Estelle, which will connect Southern Sweden and Poland from August onwards. The twin ferries are the two largest of the E-Flexer class of Stena Line and have an increased capacity of 50% more cabins, 30% more passengers and 15% more cargo vs existing E-Flexer

CapMan Buyout invests in fast-growing cybersecurity and IT services provider Netox

CapMan Buyout press releaseJuly 08 2022 at 10:00 AM EEST CapMan Buyout invests in fast-growing cybersecurity and IT services provider Netox CapMan Buyout has entered into an agreement to invest in fast-growing cybersecurity and IT services provider Netox. The company holds a unique offering and business model, especially suitable for SMEs and public sector clients. The company has grown rapidly over the past years, all the while building and maintaining a strong winning culture and attracting highly skilled professionals within the sector. CapMan Buyout will acquire a

Vattenfall’s wind power reduces carbon footprint

The carbon footprint of Vattenfall’s wind power has now been reduced to 13 grammes per kilowatt hour generated, compared to 15 grammes in 2016, and the reduction trend only continues. The new Swedish wind farm Blakliden Fäbodberget landed at a record low 8 g CO2/kWh. In this case, this is a 47 per cent reduction in emissions compared to six years ago. In addition, the difference from fossil-based electricity generation is huge.The positive downward trend for the carbon footprint of Vattenfall’s wind power continues. When compared with fossil electricity generation, it shows what a big

BioStock: Swedish life science market is the most active in Europe

Life science is one of Sweden’s most important industries with a rapid growth rate and a high degree of innovation. In ten years, the industry’s exports have increased by 60 per cent. BioStock takes a closer look at what makes Swedish life science so successful and what is required for continued growth.Read the full article about swedish life science on biostock.com: https://www.biostock.se/en/?p=42358 This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.com 

Epiroc wins large mining equipment order in Mexico

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has won a large order for a variety of underground mining equipment and automation solutions from Fresnillo plc in Mexico.Fresnillo , the world’s leading silver producer and Mexico’s largest gold producer, has ordered multiple Epiroc underground mining machines for use at five of its mines. The order is valued at about MUSD 17 (MSEK 170) and was booked in the first and second quarters 2022, whereof about MUSD 14 (MSEK 140) in the

Solasia acquires episil oral liquid business from Camurus

Lund, Sweden and Tokyo, Japan — 8 July 2022 — Camurus AB (NASDAQ STO: CAMX, hereinafter “Camurus”) and Solasia Pharma K.K. (TSE: 4597, hereinafter “Solasia”) today jointly announced that they have entered into an agreement in which Solasia has acquired episil[®] oral liquid (episil, SP-03, hereinafter “episil”), a unique and effective treatment for intra-oral pain associated with e.g. oral mucositis, from Camurus and been granted relevant IP rights.  Under the terms of the agreement, Solasia has obtained the assets and relevant worldwide licensing rights to continue developing,

Episealer® Knee technology and clinical results to be presented at European congress

Episurf Medical (Nasdaq: EPIS B) today announces that the Episealer® Knee technology and clinical results are being presented at the 5[th] International Conference on Meniscus Science and Surgery (Luxembourg, July 7-9, 2022). The presentation is held by Prof Karl Eriksson from Stockholm South Hospital and The Karolinska Institute, Stockholm, Sweden. The presentation will focus on the expected clinical outcome after resurfacing of cartilage defects in the knee, and the latest results from an ongoing European multicentre study will be presented as a part of the presentation. “The segment

There are no items matching the current filter
There are no more items matching the current filter
Back to top